Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin

Frameworks that associate cancer dynamic disease progression models with parametric survival models for clinical outcome have recently been proposed to support decision making in early clinical development. Here we developed such a disease progression clinical outcome model for castration-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hasselt, JGC, Gupta, A, Hussein, Z, Beijnen, JH, Schellens, JHM, Huitema, ADR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544052/
https://www.ncbi.nlm.nih.gov/pubmed/26312162
http://dx.doi.org/10.1002/psp4.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544052/
https://www.ncbi.nlm.nih.gov/pubmed/26312162
http://dx.doi.org/10.1002/psp4.49

Ejemplares similares